SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019300
Filing Date
2016-05-13
Accepted
2016-05-13 08:35:20
Documents
48
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-10q_20160331.htm 10-Q 875203
2 EX-31.1 vtvt-ex311_6.htm EX-31.1 16199
3 EX-31.2 vtvt-ex312_7.htm EX-31.2 16091
4 EX-32.1 vtvt-ex321_8.htm EX-32.1 7257
5 EX-32.2 vtvt-ex322_9.htm EX-32.2 7212
6 GRAPHIC gyp1wdsg5cjs000001.jpg GRAPHIC 21177
  Complete submission text file 0001564590-16-019300.txt   2921223

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vtvt-20160331.xml EX-101.INS 335515
8 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20160331.xsd EX-101.SCH 34035
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20160331_cal.xml EX-101.CAL 29327
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20160331_def.xml EX-101.DEF 122192
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20160331_lab.xml EX-101.LAB 248301
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20160331_pre.xml EX-101.PRE 193152
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 161645974
SIC: 2834 Pharmaceutical Preparations